Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 201 record(s)

Req # A-2022-001355

Adverse Drug Reactions (ADRs) for . Report numbers: E2B_05933342, 001018852. ADRs for PANTOPRAZOLE SODIUM. Report numbers: E2B_05917203, E2B_05917057, E2B_05906789, E2B_05916968, E2B_05925115. ADRs for AMPHETAMINE ASPARTATE MONOHYDRATE / AMPHETAMINE SULFATE / DEXTROAMPHETAMINE SACCHARATE / DEXTROAMPHETAMINE SULFATE. Report numbers: 001018915, 001017866. ADR for MEZAVANT. Report number: 001018374.

Organization: Health Canada

363 page(s)
March 2023

Req # A-2022-001360

Adverse Drug Reaction (ADR) for ZOSTAVAX II. Report number: 000687988. ADR for ONCOTICE. Report number: 000914673. ADRs for PNEUMOVAX 23. Report numbers: 000664078, E2B_01976711, E2B_02617912, E2B_00506085, E2B_02617883, E2B_00179953, E2B_01976711, E2B_02617912.

Organization: Health Canada

893 page(s)
March 2023

Req # A-2022-001386

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075320-264.

Organization: Health Canada

14 page(s)
March 2023

Req # A-2022-001387

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-107980-705.

Organization: Health Canada

4 page(s)
March 2023

Req # A-2022-001406

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110432-515, What We Heard Report During the 2022 Consultations on the Targeted Review of the Pest Control Products Act.

Organization: Health Canada

82 page(s)
March 2023

Req # A-2022-001409

Adverse Drug Reaction (ADR). Report number: 000722991.

Organization: Health Canada

8 page(s)
March 2023

Req # A-2022-001430

Adverse Drug Reactions (ADRs). Report numbers: 001022579, 001023009, 001023011, 001023018, 001023036.

Organization: Health Canada

32 page(s)
March 2023

Req # A-2022-001433

Adverse Drug Reaction (ADR). Report number: 000997976.

Organization: Health Canada

6 page(s)
March 2023

Req # A-2022-001434

Adverse Drug Reaction (ADR) for SOLIRIS. Report number: E2B_05935628.

Organization: Health Canada

14 page(s)
March 2023

Req # A-2022-001438

Adverse Drug Reaction (ADR). Report number: E2B_05886951.

Organization: Health Canada

19 page(s)
March 2023
Date modified: